SlideShare a Scribd company logo
STUDY OF HEMATOLOGICAL PARAMETERS IN SEPSIS PATIENTS AND ITS PROGNOSTIC IMPLICATIONS
DR. RAHUL GUPTA
Department of Medicine, N.S.C.B.Medical College & Hospital, Jabalpur (MP)
INTRODUCTION
•Systemic inflammatory response syndrome (SIRS) is defined by parameters namely body temperature of >38oC or <36oC,
leucocyte count of >12,000 cells/cumm or <4000 cells/cumm, heart rate >90/min, and respiratory rate of >24/min. If these
symptoms are complicated by organ dysfunction and persistent arterial hypotension, the definition of “severe sepsis” and “septic
shock” respectively are fulfilled.
•The mortality in patients with severe sepsis ranges from 28 to 50% or greater. In USA, incidence of sepsis rose by 7-8% over a
period of 8 years. According to the Indian intensive care case mix and practice patterns study (INDICAPS), mortality in sepsis in
India is 42.2%.
AIMS & OBJECTIVES
The current study aims :
•To study the correlation of
various hematological
parameters in sepsis
patients
•To study their effect in
prognosis of sepsis patients
MATERIALS & METHODS
The present study is a cross-
sectional observational study
done at Netaji Subhash Chandra
Bose Medical College, Jabalpur
between March 2017 to August
2018 with a total sample size
of117 patients.
•Inclusion criteria: 1.Patient
willing to be a part of study
2.Patients with SIRS.
• Exclusion criteria: 1.Patient not
willing; 2.Blood transfusion in
previous week of admission
3.Bleeding >10% of blood
volume 4.Recent chemotherapy
5.Use of drugs which affects
morphology of RBC.
Various hematological
parameters of all the patients
were obtained on day 1 and day
7 using hemogram reports and
the difference of their statistical
mean and standard deviation
was estimated using SPSS
Windows version 22 software.
OBSERVATIONS & RESULTS
CONCLUSION
Sepsis is a major cause of admissions
to ICU and emergency wards in any
tertiary care centre with a significant
mortality and morbidity. The
prognosis of sepsis can be important
when we can clinch the hemogram
markers early in the period of sepsis
and evaluate them according to the
etiology of the respective incidences.
Targeted approach can be initiated
early in the course of hospitalization
and may be a specific index of
hemogram could be established to
further co relate sepsis and its form in
particular diseases.
PARAMETER GROUP DAY 1 MEAN±SD DAY 7 MEAN±SD P VALUE
Total 9.40±9.21 6.95±5.67 0.003
NLCR Survivor 8.44±8.46 5.75±4.37 0.002
Non survivor 13.29±11.14 11.88±7.57 0.514
Total 58.52±9.84 59.50±10.01 0.151
RDW SD Survivor 59.05±10.37 59.59±10.60 0.483
Non survivor 56.39±7.11 59.11±7.29 0.043
Total 10.51±1.71 11.36±8.00 0.260
MPV Survivor 10.39±1.76 11.49±8.90 0.243
Non survivor 10.98±1.47 10.83±1.73 0.568
Total 16.20±0.87 16.33±0.64 0.116
PDW Survivor 16.24±0.61 16.32±0.65 0.314
Non survivor 16.01±1.54 16.40±0.59 0.236
Total 41.15±10.78 42.07±11.75 0.357
PLCR Survivor 40.52±10.22 42.03±11.66 0.180
Non survivor 43.70±12.73 42.25±12.41 0.524
Total 258.23±168.75 278.44±172.30 0.100
PLT Survivor 262.30±179.79 291.09±182.92 0.035
Non survivor 241.61±114.59 226.78±107.76 0.603
Total 2.61±1.50 2.87±1.43 0.004
PCT Survivor 2.54±1.58 2.96±1.48 0.002
Non survivor 2.40±1.10 2.50±1.17 0.779
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
Survival Non
survival
Total
54.25%
65.21%
56.41%
45.74%
34.78%
43.58%
Male
Female
15-30 yrs
31-45 yrs
46-60 yrs
>60 yrs
27.35%
26.49%
25.64%
20.51%
DISCUSSION
•An overall increase in the statistical mean and SD of NLCR and RDW SD indicates
their good prognostic significance in patients with sepsis. This has been supported by
previous studies done by Florence Riché et al & Shaikh MA et al.
•However there was no significant difference in the mean & SD of MPV, PDW and
PLCR which is contradictory to the results of a study done by Guclu E et al in 2013.
•Although a remarkable increase in the PLT count on day 7 as compared to day 1 of
observation in the survivor group signifies it to be a good prognostic factor in patients
with sepsis. Whereas a statistically significant increment in PCT values of mean and
SD of day 7 as compared to those of day 1 in the total and survivor group implies it to
be an affirmative prognostic factor in patients with sepsis.
REFERENCES
1. Riché F, Gayat E, Barthélémy R, Le Dorze M, Matéo J, Payen D. Reversal of neutrophil-tolymphocyte
count ratio in early versus late death from septic shock. Crit Care. 2015;19(1):439.
2. Guclu E, Durmaz Y, Karabay O. Effect of severe sepsis on platelet count and their indices. Afr Health Sci.
2013;13(2):333-8.
3. Shaikh MA, Yadavalli DR. Red cell distribution width as a prognostic marker in severe sepsis and septic
shock. Int J Adv Med. 2017;4(3):750.

More Related Content

What's hot

Kw - Cases - Aih Pbc Psc
Kw - Cases - Aih Pbc PscKw - Cases - Aih Pbc Psc
Kw - Cases - Aih Pbc PscNeil Theise
 
Autoimmune Hepatitis Part I
Autoimmune Hepatitis Part IAutoimmune Hepatitis Part I
Autoimmune Hepatitis Part I
Ayman Alsebaey
 
Autoimmune Hepatitis
Autoimmune HepatitisAutoimmune Hepatitis
Autoimmune Hepatitis
Elmuhtady Said FRCP FEBGH
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitis
Ahmed Abudeif
 
Primary Biliary Cholangitis
Primary Biliary CholangitisPrimary Biliary Cholangitis
Primary Biliary Cholangitis
Pratap Tiwari
 
Lupus nephritis update Ahmed Yehia
Lupus nephritis update Ahmed YehiaLupus nephritis update Ahmed Yehia
Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)
Pratap Tiwari
 
Autoimmune liver disease laboratory diagnosis
Autoimmune liver disease laboratory diagnosisAutoimmune liver disease laboratory diagnosis
Autoimmune liver disease laboratory diagnosis
Dr. Rajesh Bendre
 
SS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infectionSS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infection
Sri Lanka College of Sexual Health and HIV Medicine
 
Calcineurin inhibitors in lupus nephritis
Calcineurin inhibitors in lupus nephritisCalcineurin inhibitors in lupus nephritis
Calcineurin inhibitors in lupus nephritis
MohammadhassanJokar
 
Occult hcv infection the updated knowledge
Occult hcv infection the updated knowledge Occult hcv infection the updated knowledge
Occult hcv infection the updated knowledge
Monkez M Yousif
 
Calcineurin inhibitors in lupus nephritis.
Calcineurin inhibitors in lupus nephritis.Calcineurin inhibitors in lupus nephritis.
Calcineurin inhibitors in lupus nephritis.
MohammadhassanJokar
 
Management of lupus nephritis
Management of lupus nephritisManagement of lupus nephritis
Management of lupus nephritis
Arnab Nandy
 
Case presentation
Case presentationCase presentation
Case presentation
Mohamed Tropica
 
Acute on chronic liver failure
Acute on chronic liver failureAcute on chronic liver failure
Acute on chronic liver failure
Pratap Tiwari
 
Acute Variceal Hemorrhage
Acute Variceal HemorrhageAcute Variceal Hemorrhage
Acute Variceal Hemorrhage
Pratap Tiwari
 
ANCA vasculitis and Renal Diseases
ANCA vasculitis and Renal DiseasesANCA vasculitis and Renal Diseases
ANCA vasculitis and Renal Diseases
Malsawmkima Chhakchhuak
 
Acquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspectiveAcquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspective
Muhammad Asim Rana
 
ICU management of acute pancreatitis
ICU management of acute pancreatitis ICU management of acute pancreatitis
ICU management of acute pancreatitis
Dr. Gowtham Krishna
 

What's hot (20)

Kw - Cases - Aih Pbc Psc
Kw - Cases - Aih Pbc PscKw - Cases - Aih Pbc Psc
Kw - Cases - Aih Pbc Psc
 
Autoimmune Hepatitis Part I
Autoimmune Hepatitis Part IAutoimmune Hepatitis Part I
Autoimmune Hepatitis Part I
 
Autoimmune Hepatitis
Autoimmune HepatitisAutoimmune Hepatitis
Autoimmune Hepatitis
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitis
 
Primary Biliary Cholangitis
Primary Biliary CholangitisPrimary Biliary Cholangitis
Primary Biliary Cholangitis
 
Lupus nephritis update Ahmed Yehia
Lupus nephritis update Ahmed YehiaLupus nephritis update Ahmed Yehia
Lupus nephritis update Ahmed Yehia
 
Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)
 
Autoimmune liver disease laboratory diagnosis
Autoimmune liver disease laboratory diagnosisAutoimmune liver disease laboratory diagnosis
Autoimmune liver disease laboratory diagnosis
 
A Case of ANCA Vasculitis
A Case of ANCA VasculitisA Case of ANCA Vasculitis
A Case of ANCA Vasculitis
 
SS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infectionSS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infection
 
Calcineurin inhibitors in lupus nephritis
Calcineurin inhibitors in lupus nephritisCalcineurin inhibitors in lupus nephritis
Calcineurin inhibitors in lupus nephritis
 
Occult hcv infection the updated knowledge
Occult hcv infection the updated knowledge Occult hcv infection the updated knowledge
Occult hcv infection the updated knowledge
 
Calcineurin inhibitors in lupus nephritis.
Calcineurin inhibitors in lupus nephritis.Calcineurin inhibitors in lupus nephritis.
Calcineurin inhibitors in lupus nephritis.
 
Management of lupus nephritis
Management of lupus nephritisManagement of lupus nephritis
Management of lupus nephritis
 
Case presentation
Case presentationCase presentation
Case presentation
 
Acute on chronic liver failure
Acute on chronic liver failureAcute on chronic liver failure
Acute on chronic liver failure
 
Acute Variceal Hemorrhage
Acute Variceal HemorrhageAcute Variceal Hemorrhage
Acute Variceal Hemorrhage
 
ANCA vasculitis and Renal Diseases
ANCA vasculitis and Renal DiseasesANCA vasculitis and Renal Diseases
ANCA vasculitis and Renal Diseases
 
Acquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspectiveAcquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspective
 
ICU management of acute pancreatitis
ICU management of acute pancreatitis ICU management of acute pancreatitis
ICU management of acute pancreatitis
 

Similar to poster presentation Study of hematological parameters in sepsis patients and its prognostic implications

study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...
RahulGupta1687
 
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
iosrjce
 
THE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docx
THE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docxTHE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docx
THE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docx
yudistiraanwar1
 
atypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptxatypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptx
DrSrinivasJayanthur
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
semualkaira
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
semualkaira
 
Role of procalcitonin in sepsis management
Role of procalcitonin in sepsis managementRole of procalcitonin in sepsis management
Role of procalcitonin in sepsis management
MOHAMMAD NOUR AL SAEED
 
Biomarkers in Emergency Medicine: Katrin Hruska
Biomarkers in Emergency Medicine: Katrin HruskaBiomarkers in Emergency Medicine: Katrin Hruska
Biomarkers in Emergency Medicine: Katrin Hruska
SMACC Conference
 
SYNOPSIS about dengue fever 2 PPT.pptx
SYNOPSIS about dengue fever   2 PPT.pptxSYNOPSIS about dengue fever   2 PPT.pptx
SYNOPSIS about dengue fever 2 PPT.pptx
ManojMShetty2
 
Nov journal watch
Nov journal watchNov journal watch
Nov journal watch
katejohnpunag
 
4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...
4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...
4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...
JafarAbbas18
 
April journal watch
April journal watchApril journal watch
April journal watch
katejohnpunag
 
Schold
ScholdSchold
Schold
samvicttor
 
Louvet et al-2007-hepatology
Louvet et al-2007-hepatologyLouvet et al-2007-hepatology
Louvet et al-2007-hepatology
Virginia Mason Internal Medicine Residency
 
mnssmnvs.pptx
mnssmnvs.pptxmnssmnvs.pptx
mnssmnvs.pptx
MakmurSejati2
 
Recent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian Xiao
Recent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian XiaoRecent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian Xiao
Recent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian Xiao
spa718
 
Dr Bhargav kiran general medicine Dissertation Protocol
Dr Bhargav kiran  general medicine Dissertation ProtocolDr Bhargav kiran  general medicine Dissertation Protocol
Dr Bhargav kiran general medicine Dissertation Protocol
Bhargav Kiran
 
Sepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainSepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet Jain
Puneet Jain
 

Similar to poster presentation Study of hematological parameters in sepsis patients and its prognostic implications (20)

study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...
 
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
Serum Procalcitonin as a marker of infection in chronic kidney disease patien...
 
THE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docx
THE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docxTHE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docx
THE RELATIONSHIP OF SIC and CLINICAL OUTCOME.docx
 
atypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptxatypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptx
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
 
Role of procalcitonin in sepsis management
Role of procalcitonin in sepsis managementRole of procalcitonin in sepsis management
Role of procalcitonin in sepsis management
 
Biomarkers in Emergency Medicine: Katrin Hruska
Biomarkers in Emergency Medicine: Katrin HruskaBiomarkers in Emergency Medicine: Katrin Hruska
Biomarkers in Emergency Medicine: Katrin Hruska
 
SYNOPSIS about dengue fever 2 PPT.pptx
SYNOPSIS about dengue fever   2 PPT.pptxSYNOPSIS about dengue fever   2 PPT.pptx
SYNOPSIS about dengue fever 2 PPT.pptx
 
Nov journal watch
Nov journal watchNov journal watch
Nov journal watch
 
4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...
4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...
4-Journal of Medical Virology - 2021 - Zhang - Using different machine learni...
 
April journal watch
April journal watchApril journal watch
April journal watch
 
Schold
ScholdSchold
Schold
 
Louvet et al-2007-hepatology
Louvet et al-2007-hepatologyLouvet et al-2007-hepatology
Louvet et al-2007-hepatology
 
mnssmnvs.pptx
mnssmnvs.pptxmnssmnvs.pptx
mnssmnvs.pptx
 
Recent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian Xiao
Recent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian XiaoRecent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian Xiao
Recent advances in treatment of Myelodysplastic Syndrome. Dr. Zhijian Xiao
 
Dr Bhargav kiran general medicine Dissertation Protocol
Dr Bhargav kiran  general medicine Dissertation ProtocolDr Bhargav kiran  general medicine Dissertation Protocol
Dr Bhargav kiran general medicine Dissertation Protocol
 
And the winner is... smart doctors
And the winner is... smart doctorsAnd the winner is... smart doctors
And the winner is... smart doctors
 
Sepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainSepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet Jain
 
Curb 65 thorax-2003-lim-377-82
Curb 65 thorax-2003-lim-377-82Curb 65 thorax-2003-lim-377-82
Curb 65 thorax-2003-lim-377-82
 

Recently uploaded

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 

Recently uploaded (20)

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 

poster presentation Study of hematological parameters in sepsis patients and its prognostic implications

  • 1. STUDY OF HEMATOLOGICAL PARAMETERS IN SEPSIS PATIENTS AND ITS PROGNOSTIC IMPLICATIONS DR. RAHUL GUPTA Department of Medicine, N.S.C.B.Medical College & Hospital, Jabalpur (MP) INTRODUCTION •Systemic inflammatory response syndrome (SIRS) is defined by parameters namely body temperature of >38oC or <36oC, leucocyte count of >12,000 cells/cumm or <4000 cells/cumm, heart rate >90/min, and respiratory rate of >24/min. If these symptoms are complicated by organ dysfunction and persistent arterial hypotension, the definition of “severe sepsis” and “septic shock” respectively are fulfilled. •The mortality in patients with severe sepsis ranges from 28 to 50% or greater. In USA, incidence of sepsis rose by 7-8% over a period of 8 years. According to the Indian intensive care case mix and practice patterns study (INDICAPS), mortality in sepsis in India is 42.2%. AIMS & OBJECTIVES The current study aims : •To study the correlation of various hematological parameters in sepsis patients •To study their effect in prognosis of sepsis patients MATERIALS & METHODS The present study is a cross- sectional observational study done at Netaji Subhash Chandra Bose Medical College, Jabalpur between March 2017 to August 2018 with a total sample size of117 patients. •Inclusion criteria: 1.Patient willing to be a part of study 2.Patients with SIRS. • Exclusion criteria: 1.Patient not willing; 2.Blood transfusion in previous week of admission 3.Bleeding >10% of blood volume 4.Recent chemotherapy 5.Use of drugs which affects morphology of RBC. Various hematological parameters of all the patients were obtained on day 1 and day 7 using hemogram reports and the difference of their statistical mean and standard deviation was estimated using SPSS Windows version 22 software. OBSERVATIONS & RESULTS CONCLUSION Sepsis is a major cause of admissions to ICU and emergency wards in any tertiary care centre with a significant mortality and morbidity. The prognosis of sepsis can be important when we can clinch the hemogram markers early in the period of sepsis and evaluate them according to the etiology of the respective incidences. Targeted approach can be initiated early in the course of hospitalization and may be a specific index of hemogram could be established to further co relate sepsis and its form in particular diseases. PARAMETER GROUP DAY 1 MEAN±SD DAY 7 MEAN±SD P VALUE Total 9.40±9.21 6.95±5.67 0.003 NLCR Survivor 8.44±8.46 5.75±4.37 0.002 Non survivor 13.29±11.14 11.88±7.57 0.514 Total 58.52±9.84 59.50±10.01 0.151 RDW SD Survivor 59.05±10.37 59.59±10.60 0.483 Non survivor 56.39±7.11 59.11±7.29 0.043 Total 10.51±1.71 11.36±8.00 0.260 MPV Survivor 10.39±1.76 11.49±8.90 0.243 Non survivor 10.98±1.47 10.83±1.73 0.568 Total 16.20±0.87 16.33±0.64 0.116 PDW Survivor 16.24±0.61 16.32±0.65 0.314 Non survivor 16.01±1.54 16.40±0.59 0.236 Total 41.15±10.78 42.07±11.75 0.357 PLCR Survivor 40.52±10.22 42.03±11.66 0.180 Non survivor 43.70±12.73 42.25±12.41 0.524 Total 258.23±168.75 278.44±172.30 0.100 PLT Survivor 262.30±179.79 291.09±182.92 0.035 Non survivor 241.61±114.59 226.78±107.76 0.603 Total 2.61±1.50 2.87±1.43 0.004 PCT Survivor 2.54±1.58 2.96±1.48 0.002 Non survivor 2.40±1.10 2.50±1.17 0.779 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% Survival Non survival Total 54.25% 65.21% 56.41% 45.74% 34.78% 43.58% Male Female 15-30 yrs 31-45 yrs 46-60 yrs >60 yrs 27.35% 26.49% 25.64% 20.51% DISCUSSION •An overall increase in the statistical mean and SD of NLCR and RDW SD indicates their good prognostic significance in patients with sepsis. This has been supported by previous studies done by Florence Riché et al & Shaikh MA et al. •However there was no significant difference in the mean & SD of MPV, PDW and PLCR which is contradictory to the results of a study done by Guclu E et al in 2013. •Although a remarkable increase in the PLT count on day 7 as compared to day 1 of observation in the survivor group signifies it to be a good prognostic factor in patients with sepsis. Whereas a statistically significant increment in PCT values of mean and SD of day 7 as compared to those of day 1 in the total and survivor group implies it to be an affirmative prognostic factor in patients with sepsis. REFERENCES 1. Riché F, Gayat E, Barthélémy R, Le Dorze M, Matéo J, Payen D. Reversal of neutrophil-tolymphocyte count ratio in early versus late death from septic shock. Crit Care. 2015;19(1):439. 2. Guclu E, Durmaz Y, Karabay O. Effect of severe sepsis on platelet count and their indices. Afr Health Sci. 2013;13(2):333-8. 3. Shaikh MA, Yadavalli DR. Red cell distribution width as a prognostic marker in severe sepsis and septic shock. Int J Adv Med. 2017;4(3):750.